To provide long-term capital growth from investment in stocks and shares.
Name | % Net Assets |
---|---|
Royal Dutch Shell | 7.7% |
BP | 7.0% |
HSBC | 6.0% |
GlaxoSmithKline | 5.3% |
AstraZeneca | 4.0% |
Vodafone | 3.9% |
Barclays | 2.4% |
BHP Billiton | 2.3% |
JPM UK Smaller Companies Fund | 2.2% |
Reckitt Benckiser | 2.1% |
Key | % Net Assets |
---|---|
Royal Dutch Shell | 7.7% |
BP | 7.0% |
HSBC | 6.0% |
GlaxoSmithKline | 5.3% |
Other | 74% |
Date | 29-Aug-2013 |
---|---|
NAV | 401.30p |
Currency | GBP |
Change | -2.00p |
% | -0.50% |
YTD change | 401.30p |
YTD % | n/a |
Fund Inception | 09/11/1982 |
---|---|
Fund Manager | Michael Barakos / David Allen |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.04 |
You are here: research